Cargando…

Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression

HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Basilissi, Matteo, Tincati, Camilla, Merlini, Esther, Ancona, Giuseppe, Borghi, Elisa, Borgo, Francesca, Barassi, Alessandra, d’Arminio Monforte, Antonella, Marchetti, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375585/
https://www.ncbi.nlm.nih.gov/pubmed/30763359
http://dx.doi.org/10.1371/journal.pone.0212075
_version_ 1783395386605436928
author Basilissi, Matteo
Tincati, Camilla
Merlini, Esther
Ancona, Giuseppe
Borghi, Elisa
Borgo, Francesca
Barassi, Alessandra
d’Arminio Monforte, Antonella
Marchetti, Giulia
author_facet Basilissi, Matteo
Tincati, Camilla
Merlini, Esther
Ancona, Giuseppe
Borghi, Elisa
Borgo, Francesca
Barassi, Alessandra
d’Arminio Monforte, Antonella
Marchetti, Giulia
author_sort Basilissi, Matteo
collection PubMed
description HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the underlying pathogenic mechanisms of these phenomena. Twenty-six HIV-infected subjects were assessed over a 12-month period following the introduction of antiretroviral therapy. 18 uninfected individuals were enrolled as controls. Parameters of peripheral T-cell homeostasis (activation, maturation), gastrointestinal function (microbial translocation, gut inflammation, fecal microbiota composition) and mucosal immunity (CD4+CCR6+CD161+, CD4+CCR9+α4β7+, stem cell memory CD4+/CD8+ T-cells) were assessed. CD4+CCR6+CD161+ cells were depleted in HIV-infected untreated subjects and maintained significantly lower levels compared to controls, despite the introduction of effective antiviral treatment. The frequency of gut-homing CD4+CCR9+α4β7+ cells was also impaired in untreated infection and correlated with the HIV RNA load and CD4+HLADR+CD38+; during therapy, we observed a contraction of this pool in the peripheral blood and the loss of its correlation with antigenic exposure/immune activation. A partial correction of the balance between stem cell memory pools and T-cell homeostasis was registered following treatment. In HIV-infected subjects with moderate immune-suppression, antiretroviral therapy has a marginal impact on mucosal immune populations which feature distinctive kinetics in the periphery, possibly reflecting their diverse recruitment from the blood to the mucosa. The persistent defects in mucosal immunity may fuel peripheral T-cell abnormalities through diverse mechanisms, including the production of IL-17/IL-22, cellular permissiveness to infection and regulation of T-lymphocyte maturation.
format Online
Article
Text
id pubmed-6375585
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63755852019-03-01 Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression Basilissi, Matteo Tincati, Camilla Merlini, Esther Ancona, Giuseppe Borghi, Elisa Borgo, Francesca Barassi, Alessandra d’Arminio Monforte, Antonella Marchetti, Giulia PLoS One Research Article HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the underlying pathogenic mechanisms of these phenomena. Twenty-six HIV-infected subjects were assessed over a 12-month period following the introduction of antiretroviral therapy. 18 uninfected individuals were enrolled as controls. Parameters of peripheral T-cell homeostasis (activation, maturation), gastrointestinal function (microbial translocation, gut inflammation, fecal microbiota composition) and mucosal immunity (CD4+CCR6+CD161+, CD4+CCR9+α4β7+, stem cell memory CD4+/CD8+ T-cells) were assessed. CD4+CCR6+CD161+ cells were depleted in HIV-infected untreated subjects and maintained significantly lower levels compared to controls, despite the introduction of effective antiviral treatment. The frequency of gut-homing CD4+CCR9+α4β7+ cells was also impaired in untreated infection and correlated with the HIV RNA load and CD4+HLADR+CD38+; during therapy, we observed a contraction of this pool in the peripheral blood and the loss of its correlation with antigenic exposure/immune activation. A partial correction of the balance between stem cell memory pools and T-cell homeostasis was registered following treatment. In HIV-infected subjects with moderate immune-suppression, antiretroviral therapy has a marginal impact on mucosal immune populations which feature distinctive kinetics in the periphery, possibly reflecting their diverse recruitment from the blood to the mucosa. The persistent defects in mucosal immunity may fuel peripheral T-cell abnormalities through diverse mechanisms, including the production of IL-17/IL-22, cellular permissiveness to infection and regulation of T-lymphocyte maturation. Public Library of Science 2019-02-14 /pmc/articles/PMC6375585/ /pubmed/30763359 http://dx.doi.org/10.1371/journal.pone.0212075 Text en © 2019 Basilissi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Basilissi, Matteo
Tincati, Camilla
Merlini, Esther
Ancona, Giuseppe
Borghi, Elisa
Borgo, Francesca
Barassi, Alessandra
d’Arminio Monforte, Antonella
Marchetti, Giulia
Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
title Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
title_full Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
title_fullStr Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
title_full_unstemmed Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
title_short Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
title_sort mucosal cell populations may contribute to peripheral immune abnormalities in hiv-infected subjects introducing cart with moderate immune-suppression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375585/
https://www.ncbi.nlm.nih.gov/pubmed/30763359
http://dx.doi.org/10.1371/journal.pone.0212075
work_keys_str_mv AT basilissimatteo mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT tincaticamilla mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT merliniesther mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT anconagiuseppe mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT borghielisa mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT borgofrancesca mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT barassialessandra mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT darminiomonforteantonella mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression
AT marchettigiulia mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression